Naloxegol Oxalate Patent Expiration

Naloxegol Oxalate is Used for managing constipation caused by opioid medications. It was first introduced by Valinor Pharma Llc in its drug Movantik on Sep 16, 2014.


Naloxegol Oxalate Patents

Given below is the list of patents protecting Naloxegol Oxalate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Movantik US9012469 Crystalline naloxol-peg conjugate Apr 02, 2032 Valinor
Movantik US7786133 Chemically modified small molecules Sep 16, 2028 Valinor
Movantik US8067431 Chemically modified small molecules Dec 16, 2024 Valinor
Movantik US7056500 Polymer conjugates of opioid antagonists Jun 29, 2024

(Expired)

Valinor
Movantik US7662365 Polymer conjugates of opioid antagonists Oct 18, 2022

(Expired)

Valinor
Movantik US8617530 Polymer conjugates of opioid antagonists Oct 18, 2022

(Expired)

Valinor



Naloxegol Oxalate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List